Swiss National Bank’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-89,600
Closed -$259K – 2353
2025
Q1
$259K Sell
89,600
-13,700
-13% -$55.6K ﹤0.01% 2393
2024
Q4
$425K Hold
103,300
– – ﹤0.01% 2416
2024
Q3
$462K Hold
103,300
– – ﹤0.01% 2444
2024
Q2
$564K Hold
103,300
– – ﹤0.01% 2391
2024
Q1
$834K Buy
103,300
+2,900
+3% +$25.6K ﹤0.01% 2306
2023
Q4
$998K Buy
100,400
+3,500
+4% +$27.5K ﹤0.01% 2241
2023
Q3
$774K Buy
96,900
+3,200
+3% +$32.1K ﹤0.01% 2380
2023
Q2
$1.03M Buy
93,700
+14,300
+18% +$147K ﹤0.01% 2276
2023
Q1
$820K Sell
79,400
-5,500
-6% -$64.8K ﹤0.01% 2359
2022
Q4
$933K Buy
84,900
+4,500
+6% +$57.8K ﹤0.01% 2382
2022
Q3
$1.25M Hold
80,400
– – ﹤0.01% 2200
2022
Q2
$1.84M Buy
+80,400
New +$1.72M ﹤0.01% 1981

Other funds holding DH

Swiss National Bank's DH Position: Q2 2025 in Review

Swiss National Bank sold out of Definitive Healthcare (DH) in Q2 2025, closing a stake of 89,600 shares — an estimated $259K sold.

Swiss National Bank first reported a position in DH in Q2 2022 and held it in 12 quarters. The position peaked at $1.84M in Q2 2022. 121 funds tracked by Wall St. Rank hold DH as of Q2 2025.

  • Swiss National Bank reported no remaining Definitive Healthcare position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 89,600 Definitive Healthcare shares in Q2 2025, an estimated $259K.
  • Swiss National Bank first reported a position in Definitive Healthcare in Q2 2022 and held it in 12 quarters.
  • Swiss National Bank's Definitive Healthcare position peaked at $1.84M in Q2 2022.
  • 121 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.